PCORI Awards UNC Researcher $14.4 Million to Study Emerging Medications for PIBD Patients
The Patient-Centered Outcomes Research Institute (PCORI) announced funding totaling $14.4 million for a Duke-UNC research collaboration to study new treatment options for pediatric inflammatory bowel diseases (PIBD). Michael D. Kappelman, MD, MPH, professor of pediatrics and epidemiology at the UNC School of Medicine, will serve as principal investigator.